Medical Union PharmaceuticalsR.C51MUP established in 1984 to develop regional pharmaceutical market.MUP becomes leading international pharmaceutical company, generating revenue of around 2.4 Billion LE in 2018. We have a balanced business model for sustainability, covering branded generics and biosimilar that are well diversified by geography and product. We have operations in more than 40 countries across three continents, employing 2,357 people globally.We develop, manufacture and market a broad range of branded and non-branded generic pharmaceutical products across the ME, Africa, CIS and East Europe.Our primary objective is to improve lives by providing patients with high-quality, affordable medicines while creating long-term value for shareholders and building a sustainable business for our employees and communities.